Gene · 5947
Papers1,641
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,641
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of a prognostic model related to copper dependence in breast cancer by single-cell sequencing analysis. | Front Genet | 2022 | 36082002 | PubTator, text mining | PubMed |
| Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity? | Front Oncol | 2022 | 36059621 | PubTator, text mining | PubMed |
| Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications. | Front Oncol | 2022 | 36059609 | PubTator, text mining | PubMed |
| The histone methyltransferase SETD2 negatively regulates cell size. | J Cell Sci | 2022 | 36052643 | PubTator, text mining | PubMed |
| Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment. | Front Pharmacol | 2022 | 36052127 | PubTator, text mining | PubMed |
| Reversible epigenetic alterations regulate class I HLA loss in prostate cancer. | Commun Biol | 2022 | 36050516 | PubTator, text mining | PubMed |
| Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis. | BMC Cancer | 2022 | 36030212 | PubTator, text mining | PubMed |
| MicroRNA-223 Suppresses Human Hepatic Stellate Cell Activation Partly via Regulating the Actin Cytoskeleton and Alleviates Fibrosis in Organoid Models of Liver Injury. | Int J Mol Sci | 2022 | 36012644 | PubTator, text mining | PubMed |
| Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma. | Cells | 2022 | 36010607 | PubTator, text mining | PubMed |
| Unraveling the Effects of Carotenoids Accumulation in Human Papillary Thyroid Carcinoma. | Antioxidants (Basel) | 2022 | 36009182 | PubTator, text mining | PubMed |
| Expression and biochemical analyses of proteins involved in the transport of carotenoids and retinoids. | Methods Enzymol | 2022 | 36008016 | PubTator, text mining | PubMed |
| CDK9 and PP2A regulate RNA polymerase II transcription termination and coupled RNA maturation. | EMBO Rep | 2022 | 35980303 | PubTator, text mining | PubMed |
| Autophagy related DNA methylation signature predict clinical prognosis and immune microenvironment in low-grade glioma. | Transl Cancer Res | 2022 | 35966301 | PubTator, text mining | PubMed |
| Identification of critical genes associated with radiotherapy resistance in cervical cancer by bioinformatics. | Front Oncol | 2022 | 35965520 | PubTator, text mining | PubMed |
| Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer. | Front Immunol | 2022 | 35958586 | PubTator, text mining | PubMed |
| Stem Cells as Target for Prostate cancer Therapy: Opportunities and Challenges. | Stem Cell Rev Rep | 2022 | 35951166 | PubTator, text mining | PubMed |
| Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease. | Chin Med J (Engl) | 2022 | 35940901 | PubTator, text mining | PubMed |
| Identification of Genes Predicting Poor Response of Trastuzumab in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer. | J Immunol Res | 2022 | 35935587 | PubTator, text mining | PubMed |
| A comprehensive thermodynamic model for RNA binding by the Saccharomyces cerevisiae Pumilio protein PUF4. | Nat Commun | 2022 | 35927243 | PubTator, text mining | PubMed |
| UV and visible light exposure to hair leads to widespread changes in the hair lipidome. | Int J Cosmet Sci | 2022 | 35924329 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5947/papers?page=12